Almirall Investor Relations Material
Latest events
Q1 2025
Almirall
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Almirall S.A.
Access all reports
Almirall, S.A., a pharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines. The company offers dermatological products that are used in the treatment of acne, psoriasis and other inflammatory skin diseases; aesthetic products that are used in the treatment of hair loss and to promote hair regrowth; and treating and preventing the excessive growth of sebaceous glands in adults, children and infants. Its products include Epiduo, Avage, Atralin Topical Solution, Acnomel Cream, Oustiderm Scalp Lotion, Tazorac Gel and Others.
Key slides for Almirall S.A.
Q1 2025
Almirall S.A.
43rd Annual J.P. Morgan Healthcare Conference 2025
Almirall S.A.
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
ALM
Country
🇪🇸 Spain